Stock comparison
AstraZeneca PLC is 148.2x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.93 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AZN is larger
AstraZeneca PLC is 148.2x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.93 B).
Market value leader
AZN
AstraZeneca PLC is 148.2x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.93 B).
| Metric | ANAB | AZN |
|---|---|---|
| Market cap | $1.93 B | $286.27 B |
| US-listed rank | #2164 | #49 |
| Revenue (latest FY) | $234.60M | - |
| Net income (latest FY) | -$13.23M | - |
| Net margin | -5.6% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 678 | 1,004 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AstraZeneca PLC is 148.2x more valuable than ANAPTYSBIO, INC by market capitalization ($286.27 B vs $1.93 B).
Full pages: ANAPTYSBIO, INC and AstraZeneca PLC, or browse the full rankings.